ISOtretinoin

Last Updated: 02/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5785 publications

Acne Incidence and Severity in Transgender Individuals.

Acne Incidence and Severity in Transgender Individuals.

Journal: JAMA dermatology

Published: January 21, 2026

Differential retinoic acid responses across testicular development in vitro.

Differential retinoic acid responses across testicular development in vitro.

Journal: bioRxiv : the preprint server for biology

Published: January 09, 2026

Faith and Fasting in Dermatology: Ethical Dilemmas in Pharmacologic Treatment.

Faith and Fasting in Dermatology: Ethical Dilemmas in Pharmacologic Treatment.

Journal: Clinics in dermatology

Published: January 09, 2026

Concurrent Low-Dose Isotretinoin With Ablative Fractional Er:YAG Resurfacing for Acne Scars.

Concurrent Low-Dose Isotretinoin With Ablative Fractional Er:YAG Resurfacing for Acne Scars.

Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Published: January 09, 2026

Development of Digital Algorithms for the Early Identification of Rare Clinical Outcomes Using Electronic Medical Records: A Case Study of Hidradenitis Suppurativa.

Development of Digital Algorithms for the Early Identification of Rare Clinical Outcomes Using Electronic Medical Records: A Case Study of Hidradenitis Suppurativa.

Journal: Population health management

Published: December 25, 2025

Isotretinoin-related adverse sexual and reproductive outcomes: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System (FAERS).

Isotretinoin-related adverse sexual and reproductive outcomes: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System (FAERS).

Journal: Cutaneous and ocular toxicology

Published: December 25, 2025

Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case Report.

Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case Report.

Journal: The Journal of clinical and aesthetic dermatology

Published: December 19, 2025

P19 A rare case of PHOAR2-enteropathy syndrome (PHOAR2E; previously known as pachydermoperiostosis) with a causal variant in the SLCO2A1 gene.

P19 A rare case of PHOAR2-enteropathy syndrome (PHOAR2E; previously known as pachydermoperiostosis) with a causal variant in the SLCO2A1 gene.

Journal: The British journal of dermatology

Published: December 18, 2025

Performance of artificial intelligence large language models (LLMs) in answering frequently asked questions about isotretinoin.

Performance of artificial intelligence large language models (LLMs) in answering frequently asked questions about isotretinoin.

Journal: Cutaneous and ocular toxicology

Published: December 18, 2025

P05 The efficacy and safety of isotretinoin in transgender males receiving gender-affirming hormonal therapy with youth subgroup analysis: a systematic review.

P05 The efficacy and safety of isotretinoin in transgender males receiving gender-affirming hormonal therapy with youth subgroup analysis: a systematic review.

Journal: The British journal of dermatology

Published: December 18, 2025

O07 To test or not to test? Isotretinoin blood test monitoring in children and adolescents in a teaching hospital over 2 years.

O07 To test or not to test? Isotretinoin blood test monitoring in children and adolescents in a teaching hospital over 2 years.

Journal: The British journal of dermatology

Published: December 18, 2025

Clinical practice style is associated with greater isotretinoin use for acne in an integrated health system: An ecological study.

Clinical practice style is associated with greater isotretinoin use for acne in an integrated health system: An ecological study.

Journal: JAAD international

Published: December 15, 2025

Showing 1-12 of 5,785

Last Updated: 02/24/2026